With the founding of LPI gGmbH on 25.04.2024, the Leibniz Centre for Photonics in Infection Research is entering the next era. The four consortium partners of the new centre - the Leibniz Institute of Photonic Technology (Leibniz IPHT), the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz HKI), the Friedrich Schiller University Jena (FSU) and the University Hospital Jena (UKJ) - have thus taken the decisive step to consolidate the LPI as a globally unique translational infrastructure - as a bridge from research to application. LPI gGmbH will be established as an open-user one-stop agency. It combines all services, technologies and competences under one roof that are required to significantly accelerate the development and transfer of market-ready light-based diagnostic procedures and novel therapeutic approaches for the treatment of infectious diseases.
Latest News
Light-based technologies offer enormous potential in the fight against infectious diseases. Their research as well as the development of effective diagnostic methods and therapies are to be revolutionized in Jena in the coming years with the Leibniz Center for Photonics in Infection Research (LPI). In order to get to know […]
The build up phase of the Leibniz Center for Photonics in Infection Research (LPI) is now starting with the implementation of novel technologies for the translation of revolutionizing diagnosis and therapy technologies for infectious diseases: More than 100 researchers as well as representatives of the Federal Ministry of Education and Research (BMBF) and the project management agency VDI Technologiezentrum met online to present their plans for the technological equipment of the LPI.
Light-based methods are increasingly used for analytical problems in the fields of health, environment, medicine and safety. Raman spectroscopy in particular is a suitable method for this purpose. The measurement data collected in this process are complex and extensive molecular fingerprints. Artificial intelligence can help in the analysis of these Raman spectra.
Jena University Hospital is coordinating a collaborative project that is now starting to accelerate the diagnosis of viral respiratory infections. The research project will use COVID-19 to develop methods and technologies that can detect viral outbreaks earlier and support their containment to be better prepared for future epidemics.
On October 26, representatives from politics, industry and science celebrated the LPI kick-off event in Jena - emphasizing the potential that Jena, the City of Light, has as a location for the center's success.
Fighting infectious diseases with optical technologies: BMBF funds new Leibniz Center for Photonics in Infection Research with unique infrastructure
Four Jena research institutions sign cooperation agreement for Europe-wide unique research infrastructure for the investigation of light-based health technologies
Good ideas from research are to reach patients more quickly in the future. To this end, the German government is investing in a new Leibniz Research Center in Jena. Natural scientists, technology developers, physicians and medical technology manufacturers will work together there in the future to develop light-based technologies for better diagnostics and therapy of infectious diseases.
The German Council of Science and Humanities (Wissenschaftsrat) rated the plans for the "Leibniz Center for Photonics in Infection Research" (LPI) in Jena as very positive, according to the "Report on the science-led assessment of large-scale research infrastructure projects for the National Roadmap" published on Monday, July 17, 2017. From 2018, an open-user center could be created where photonic solutions for diagnostics, monitoring and experimental therapy for infections are researched and developed with industry into functional solutions.